Radionuclide Therapy - Sharing Best Practice for Safe and Optimal Services

This one-day, online event will showcase best practice and share learning gained from the delivery of molecular radiotherapy, including but not limited to Lu-177-based treatments. This will include topics such as practical aspects of safe therapy delivery, accurate and efficient methods for dosimetry, and how dosimetry services can be developed and sustained within an NHS setting.

The demand for molecular radiotherapy services has been increasing, due in part, to the introduction of new therapy types, such as Lu-177 PSMA, as well as continued demand for established therapies, such as I-131 for thyroid disease, Lu-177 dotatates and Y-90 SIRTs. The event aims to provide valuable information to the many centres that are setting up new therapy or dosimetry services to support increased demand for radionuclide therapies and the expected expansion of Lu-177 PSMA therapy across the UK.  

Abstracts and Case Studies
This meeting will be open to contributions on all aspects related to molecular radiotherapy service delivery and dosimetry. Submissions can be made using either the ‘Case study of experience’ form for sharing best practice or describing a new / amended process that has been implemented, or the standard template, for sharing research / audit results. Both types of submission are encouraged.

For guidance, terms and the abstract template, please use the submission form found here - the Case Study of Experience template is also available.

Submission deadline: 11th December 2023

Booking information will be available soon.

Contact/Queries
If you have any queries, please email the IPEM conference team or tel: 01904 550598.